Pharma Journalist 8769 posts 0 comments

AbbVie and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI),announced an exclusive licensing agreement for IGI's lead…
Read More...

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced that it has entered into a global licensing agreement with BeOne Medicines Ltd., a global oncology company, for multiple fully…
Read More...

Adcentrx Therapeutics, a clinical-stage biotech company specializing in Antibody-Drug Conjugate (ADC) therapies, announced that the U.S. Food and Drug Administration (FDA) has granted…
Read More...

Neuraxpharm Group, a leading European specialty pharmaceutical company focused on central nervous system (CNS) disorders, and Swedish R&D firm Dizlin Pharmaceuticals AB have…
Read More...

KalVista Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY (sebetralstat), a novel plasma kallikrein inhibitor, as the first and only…
Read More...

GSK plc has finalized its acquisition of efimosfermin alfa from Boston Pharmaceuticals, a promising investigational therapy targeting steatotic liver disease (SLD). Efimosfermin is a…
Read More...

Sagent Pharmaceuticals, a leading U.S. pharmaceutical provider, and China-based Qilu Pharmaceutical have entered a strategic partnership to commercialize a portfolio of complex…
Read More...

Chugai Pharmaceutical Co., Ltd., a major Japanese pharmaceutical company, and Singapore-based biotech firm Gero PTE. LTD. have announced a strategic joint research and license agreement…
Read More...

Mustang Bio, Inc., a clinical-stage biopharmaceutical company focused on cell therapies for hard-to-treat cancers, announced that the U.S. Food and Drug Administration (FDA) has granted…
Read More...

Swiss biopharmaceutical company BioVersys AG has entered into a global research and exclusive license option agreement with Japanese pharmaceutical firm Shionogi & Co., Ltd. to…
Read More...